Which disease activity outcome measure discriminates best in axial spondyloarthritis? A systematic literature review and meta-analysis
Rheumatology (Oxford)
.
2020 Dec 1;59(12):3990-3992.
doi: 10.1093/rheumatology/keaa527.
Authors
Augusta Ortolan
1
2
,
Victoria Navarro-Compán
3
,
Alexandre Sepriano
1
4
,
Robert B M Landewé
4
5
,
Désirée van der Heijde
1
,
Sofia Ramiro
1
6
Affiliations
1
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
2
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Italy.
3
Department of Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain.
4
NOVA Medical School, Universidade Nova de Lisboa, Lisboa, Portugal.
5
Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology Center, Amsterdam.
6
Department of Rheumatology, Zuyderland Medical Center, Heerlen, the Netherlands.
PMID:
33085754
DOI:
10.1093/rheumatology/keaa527
No abstract available
Publication types
Letter
Meta-Analysis
Systematic Review
MeSH terms
Humans
Randomized Controlled Trials as Topic / methods
Spondylarthritis / diagnosis*
Spondylarthritis / pathology
Spondylarthritis / therapy
Treatment Outcome